Funded Tech Companies
PTC Therapeutics
PTC Therapeutics, operating out of South Plainfield, received investment capital from private investors, HBM Healthcare Investments and Celgene.
Company Overview
Company Name
PTC Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Corporate Ct.
South Plainfield, NJ 07080
USA
South Plainfield, NJ 07080
USA
Phone
Website
Email Address
Company Background Information
Overview
PTC (NASDAQ; PTCT) is a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/20/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stuart Peltz
Chief Financial Officer
Christine Utter
Vice President
Mary Harmon
VP - General Counsel
Mark Boulding
VP - Human Resources
Martin Rexroad
VP - R & D
Neil Almstead
Company Investors
- HBM Healthcare Investments (Axel Bolte)
- Celgene
- Jennison Associates
- Adage Capital Management
- Credit Suisse
- Brookside Capital (Adam Koppel)
- Novo Ventures
- The Column Group (Peter Svennilson)
- Vulcan Capital
- Longwood Founders Fund (Richard Aldrich)
- Delphi Ventures (Deepa Pakianathan)
- The Column Group (Stuart Peltz)
- Amgen Ventures
- Novartis BioVenture Fund
- Credit Suisse (Michael Schmertzler)
- Bay City Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs